Journal
JOURNAL OF IMMUNOLOGICAL METHODS
Volume 492, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jim.2021.112994
Keywords
Histocompatibility; Immune monitoring; Immunodeficiency; Immunotherapy; Antinuclear antibodies; COVID-19
Categories
Ask authors/readers for more resources
The AMLI annual meeting was held virtually in August with topics covering histocompatibility testing, immunotherapy monitoring, and more. To address the COVID-19 pandemic, a session on antibody testing for SARS-CoV-2 infections was added to the program.
The annual meeting of the Association of Medical Laboratory Immunologists (AMLI) was convened virtually over the month of August. Prior to the emergence of the COVID-19 pandemic, AMLI's scientific committee had chosen the following topics as the focus of its 2020 meeting: Histocompatibility Testing and Transplant Immunology; Secondary Immunodeficiency and Immunotherapy Monitoring; ANA Update; and Emerging Infectious Diseases and New Algorithms for Testing. Given the central role of the discipline in the evaluation of the host response to infection, it was apt to add a separate session on antibody testing for SARS-CoV-2 infections to the original program. The current report provides an overview of the subjects discussed in the course of this meeting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available